Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences: Basic Science

Age-related olfactory loss is associated with nigrostriatal dopaminergic degeneration

Nicolaas Bohnen, Martijn Muller, Hiroto Kuwabara and Stephanie Studenski
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 106;
Nicolaas Bohnen
1VA, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martijn Muller
2University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroto Kuwabara
3Radiology, Johns Hopkins University, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Studenski
4GRECC, VA, Pittsburgh, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

106

Objectives Mechanisms of age-associated olfactory loss are poorly understood. We investigated the relationship between severity of age-associated nigrostriatal dopaminergic denervation and olfactory performance in community-dwelling subjects.

Methods Community-dwelling subjects (n=85, 50F/35M, mean age 62.7±16.2, range 20-85) underwent brain dopamine transporter (DAT) [C-11]β-CFT PET imaging and olfactory assessment using the University of Pennsylvania Smell Identification Test (UPSIT). Subjects with clinical or DAT PET evidence of Parkinson disease were not eligible for the study.

Results Increased age was associated with lower olfactory scores (R=-0.48, P<0.0001) and lower striatal DAT binding (R=-0.81, P<0.0001). Higher striatal DAT binding correlated with better olfactory scores (R=0.53, P<0.0001) that remained significant (partial R=0.27, P=0.01) while accounting for the effect of age. There was no longer a significant age-related olfactory effect after accounting for striatal DAT losses (partial R=0.10, P=0.38).

Conclusions Age-associated nigrostriatal dopaminergic degeneration is a determinant of olfactory loss with aging and may indicate a novel pathobiological mechanism. It is plausible that more significant olfactory losses in some elderly may indicate the presence of neurodegenerative disorders, and may involve pathology including dopaminergic losses.

Research Support Department of Veterans Affairs

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Age-related olfactory loss is associated with nigrostriatal dopaminergic degeneration
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Age-related olfactory loss is associated with nigrostriatal dopaminergic degeneration
Nicolaas Bohnen, Martijn Muller, Hiroto Kuwabara, Stephanie Studenski
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 106;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Age-related olfactory loss is associated with nigrostriatal dopaminergic degeneration
Nicolaas Bohnen, Martijn Muller, Hiroto Kuwabara, Stephanie Studenski
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 106;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences: Basic Science

  • A new quantitative approach for dopamine transporter binding using [11C]PE2I and PET allowing BBB-penetrating radiolabeled metabolite
  • Measurement of 5-HT1A receptor density and in vivo KD of [F-18]Mefway in the nonhuman primate
  • Activity-related changes in brain HDAC with [F-18]FAHA PET in rats and monkeys
Show more Neurosciences: Basic Science

Basic Science: Emerging Targets

  • In vivo distribution of human brain aromatase with [11C]vorozole
  • Alpha2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse
  • Initial PET evaluation of [F-18]fluoro-HEAT for central alpha-1 noradrenergic receptor imaging
Show more Basic Science: Emerging Targets

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire